Join our Community
Support ToI and remove all ads
Learn more

ISRAEL AT WAR - DAY 468

BionTech

File: A vial of Moderna COVID-19 vaccine, on a table at an inoculation station next to Jackson State University in Jackson, Mississippi, on July 19, 2022. (AP Photo/ Rogelio V. Solis)
August 26, 2022, 5:20 pm
Moderna sues Pfizer, BioNTech over patents behind COVID vaccine
Massachusetts-based firm accuses rival and its partner of copyright infringement, filing suit in both US and German courts
By Tom Murphy
Ugur Sahin, co-founder of the Mainz-based coronavirus vaccine developer BioNTech, listens during an Axel Springer Award ceremony, March 18, 2021.(Bernd von Jutrczenka/dpa via AP, Pool)
February 17, 2022, 5:00 pm
World ‘better prepared’ to deal with new COVID variants, BioNTech CEO says
New COVID variants inevitable, Ugur Sahin warns, but the world is ‘learning more’ and getting a ‘better understanding on how to deal with the virus’
By AFP
Illustrative -- A child receives a Pfizer COVID-19 vaccine in Sacramento, California, Jan. 25, 2022 (AP Photo/Rich Pedroncelli)
February 1, 2022, 8:41 am
Pfizer COVID vaccine could be available for under-5s in US by end of February
Regulators urge drugmaker to apply for emergency authorization of 2-dose regimen of shot for kids aged 6 months to 5 years old while awaiting data on 3-dose course
By AP and ToI Staff
A medical worker readies to administer the Moderna coronavirus vaccine to a Palestinian laborer at a temporary medical facility set up at a checkpoint on March 9, 2021, in Jerusalem. (Olivier Fitoussi/Flash90)
November 27, 2021, 7:59 am
Moderna says it will develop booster shot for new COVID variant
Pharmaceutical company says it is also examining using a higher dose of its existing vaccine against Omicron
By ToI Staff
A vial of the Pfizer-BioNTech COVID-19 vaccine for children 5 to 12 years old sits ready for use at a vaccination site in Fort Worth, Texas, on November 11, 2021. (LM Otero/AP)
November 26, 2021, 10:53 pm
BioNtech says it needs 2 weeks to determine vaccine’s effectiveness against Omicron
Firm that developed vaccine with Pfizer says it will have more data available next month, but has plans in motion to be able to mass-manufacture adapted inoculation
By ToI Staff
The new Tel Aviv University 'GPS-guided' nanoparticle drug, in blue and green, around an immune cell. (courtesy of Tel Aviv University)
June 29, 2021, 10:28 am
New Israeli ‘GPS’ nano-drug busts inflammation, touted as antibody replacement
Nanoparticles, tested on mice and unveiled in peer-reviewed research, head straight to cells that are inflamed, and either ‘silence’ or edit the gene that is causing inflammation
By Nathan Jeffay
Vials of the Comirnaty vaccine by Pfizer-BioNTech at the Allergopharma production facilities in Reinbek, near Hamburg, northern Germany, April 30, 2021. (Christian Charisius / POOL / AFP)
May 3, 2021, 7:50 pm
EU drug agency starts evaluating Pfizer vaccine for 12- to 15-year olds
European Medicines Agency says it will carry out ‘accelerated assessment of data’ on shot when submitted by its producers
By AFP and ToI Staff
Ugur Sahin, co-founder of the Mainz-based coronavirus vaccine developer BioNTech, listens during an Axel Springer Award ceremony, March 18, 2021.(Bernd von Jutrczenka/dpa via AP, Pool)
April 28, 2021, 6:07 pm
BioNTech chief ‘confident’ Pfizer vaccine works against Indian virus strain
Ugur Sahin, co-founder of company that jointly developed leading COVID-19 inoculation, says shots have proved effective against other similar mutations
By AFP and ToI Staff
A photo taken on March 27, 2021 shows the logo on the facade of the new manufacturing site of German company BioNTech for the production of the vaccine against the coronavirus (COVID-19) in Marburg, central Germany. (Thomas Lohnes / AFP)
March 30, 2021, 4:08 pm
BioNTech, Pfizer’s vaccine partner, increases output goal to 2.5 billion doses
German company on track to manufacture 25% more shots than initially expected, including 250 million in the first half of 2021
By AFP
Ozlem Tureci, founder of BioNTech, speaks during an interview in Berlin, Germany, Thursday, March 18, 2021. (AP Photo/Michael Sohn)
March 19, 2021, 4:56 pm
Scientist behind Pfizer vaccine: mRNA shots for cancer coming ‘in couple years’
BioNTech’s Ozlem Tureci says the know-how behind revolutionary inoculations could soon be used to treat far more than the coronavirus pandemic
By Frank Jordans
A nurse receives the Pfizer-Biontech coronavirus vaccine at the Helsinki University Hospital in Helsinki, Finland on December 27, 2020 (Alessandro RAMPAZZO / AFP)
January 5, 2021, 3:56 pm
BioNTech, Pfizer’s vaccine partner, warns against delaying 2nd dose
German firm says there’s no data showing ‘that protection after the first dose is sustained after 21 days,’ as some countries weigh move to allow more people to get inoculated
By AFP
Doses of the Pfizer-Biontech COVID-19 coronavirus vaccine at a vaccination center in Magdeburg, eastern Germany, on December 27, 2020. (Ronny Hartmann / POOL / AFP)
December 27, 2020, 11:54 am
How BioNTech-Pfizer won the great global coronavirus vaccine race
As the German biotechnology firm worked on a shot to defeat virus, other companies around the country already began organizing the infrastructure needed to deliver it to billions
By Hui Min NEO, Yannick Pasquet, Michelle Fitzpatrick and Yann Schreiber
Ugur Sahin, CEO of Biontech, gestures during an interview in Mainz, Germany, November 27, 2019. (Andreas Arnold/dpa via AP)
December 22, 2020, 12:32 pm
BioNTech CEO confident vaccine developed with Pfizer works on UK virus variant
Head of German pharmaceutical company says it will take another two weeks to get enough data to know for sure if inoculation effective against more contagious mutated strain
By AP and ToI Staff
Illustrative. A syringe and a bottle reading 'COVID-19 Vaccine' next to the Pfizer company logo, November 23, 2020. (JOEL SAGET / AFP)
December 1, 2020, 1:36 pm
Pfizer, BioNTech ask Europe to approve coronavirus vaccine
Companies say shot, if authorized for use, could be rolled out before end of year; German science minister says safety standards are being maintained
By Agencies and ToI Staff
University of Miami Miller School of Medicine lab technician processing blood samples from study participants who volunteered to take part in testing the National Institutes of Health-funded Moderna COVID-19 vaccine in Miami, September 2, 2020. (AP Photo/Taimy Alvarez, File)
November 30, 2020, 3:12 pm
Moderna seeks US, EU approval for vaccine as final results show 94% efficacy
‘I allowed myself to cry for the first time’ when learning of the results, says Israeli chief medical officer as pharma firm asks regulators to allow emergency use of the jab
By Agencies and ToI Staff
Load More
Sign in or Register
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering also lets you comment on articles and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.